VOYA Investment Management
KROS icon

VOYA Investment Management’s Keros Therapeutics KROS Stock Holding History

VOYA Investment Management’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-29,488
Closed -$467K – 2690
2024
Q4 		$467K Sell
29,488
-145,806
-83% -$7.58M ﹤0.01% 1965
2024
Q3 		$10.2M Buy
175,294
+119,197
+212% +$5.89M 0.01% 759
2024
Q2 		$2.56M Sell
56,097
-3,176
-5% -$171K ﹤0.01% 1240
2024
Q1 		$3.92M Buy
59,273
+25,638
+76% +$1.52M ﹤0.01% 1096
2023
Q4 		$1.34M Sell
33,635
-38,511
-53% -$1.21M ﹤0.01% 1523
2023
Q3 		$2.3M Buy
72,146
+154
+0.2% +$5.75K ﹤0.01% 1277
2023
Q2 		$2.89M Buy
71,992
+1,808
+3% +$79.3K ﹤0.01% 1210
2023
Q1 		$3M Hold
70,184
– – ﹤0.01% 1185
2022
Q4 		$3.37M Sell
70,184
-17,226
-20% -$805K ﹤0.01% 1121
2022
Q3 		$3.29M Buy
+87,410
New +$3.03M ﹤0.01% 1129
2022
Q2 		– Sell
-6,131
Closed -$333K – 2837
2022
Q1 		$333K Hold
6,131
– – ﹤0.01% 2126
2021
Q4 		$359K Buy
6,131
+25
+0.4% +$1.25K ﹤0.01% 2200
2021
Q3 		$242K Hold
6,106
– – ﹤0.01% 2467
2021
Q2 		$259K Buy
6,106
+122
+2% +$6.61K ﹤0.01% 2455
2021
Q1 		$368K Buy
5,984
+504
+9% +$31.9K ﹤0.01% 2194
2020
Q4 		$387K Buy
+5,480
New +$345K ﹤0.01% 2063

Other funds holding KROS

Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

VOYA Investment Management's KROS Position: Q1 2025 in Review

VOYA Investment Management sold out of Keros Therapeutics (KROS) in Q1 2025, closing a stake of 29,488 shares — an estimated $467K sold.

VOYA Investment Management first reported a position in KROS in Q4 2020 and held it in 16 quarters. The position peaked at $10.2M in Q3 2024. 156 funds tracked by Wall St. Rank hold KROS as of Q1 2025.

  • VOYA Investment Management reported no remaining Keros Therapeutics position as of Q1 2025 after selling out during the quarter.
  • VOYA Investment Management sold 29,488 Keros Therapeutics shares in Q1 2025, an estimated $467K.
  • VOYA Investment Management first reported a position in Keros Therapeutics in Q4 2020 and held it in 16 quarters.
  • VOYA Investment Management's Keros Therapeutics position peaked at $10.2M in Q3 2024.
  • 156 funds tracked by Wall St. Rank held Keros Therapeutics as of Q1 2025.

Based on VOYA Investment Management's 13F filing for Q1 2025, filed 15 May 2025.